{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T20:00:32Z","timestamp":1648843232331},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,6,1]],"date-time":"2011-06-01T00:00:00Z","timestamp":1306886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice & Research Clinical Haematology"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1016\/j.beha.2011.02.008","type":"journal-article","created":{"date-parts":[[2011,4,18]],"date-time":"2011-04-18T16:07:16Z","timestamp":1303142836000},"page":"179-186","source":"Crossref","is-referenced-by-count":2,"title":["Treatment strategies in limited stage follicular NHL"],"prefix":"10.1016","volume":"24","author":[{"given":"Richard T.","family":"Hoppe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.beha.2011.02.008_bib1","first-page":"981","article-title":"Clinical and surgical (laparotomy) evaluation of patients with non-Hodgkin\u2019s lymphomas","volume":"61","author":"Goffinet","year":"1977","journal-title":"Cancer Treat Rep"},{"issue":"1","key":"10.1016\/j.beha.2011.02.008_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijrobp.2007.09.051","article-title":"Impact of [18f] fluorodeoxyglucose positron emission tomography on staging and management of early-stage follicular non-hodgkin lymphoma","volume":"71","author":"Wirth","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.beha.2011.02.008_bib3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1080\/1042819031000159303","article-title":"Possible influence of clinical stage and type of treatment in the persistence of residual circulating t(14;18)-positive cells in follicular lymphoma patients","volume":"45","author":"Colleoni","year":"2004","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"10.1016\/j.beha.2011.02.008_bib4","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S0360-3016(00)01416-4","article-title":"The significance of molecular response of follicular lymphoma to central lymphatic irradiation as measured by polymerase chain reaction for t(14;18)(q32;q21)","volume":"49","author":"Ha","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.beha.2011.02.008_bib5","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1365-2141.2007.06545.x","article-title":"Stage I\/II follicular lymphoma: spread of bcl-2\/IgH+ cells in blood and bone marrow from primary site of disease and possibility of clearance after involved field radiotherapy","volume":"137","author":"Pulsoni","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.beha.2011.02.008_bib6","unstructured":"NCI. Surveillance, Epidemiology, and End Results (SEER) Cancer statistics review. In: Table 19.7 N-HL, editor. The Surveillance, Epidemiology, and End Results (SEER) Program 1975\u20132006."},{"issue":"3","key":"10.1016\/j.beha.2011.02.008_bib7","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0959-8049(95)00607-9","article-title":"The follicular non-Hodgkin\u2019s lymphomas\u2013I. The possibility of cure","volume":"32A","author":"Denham","year":"1996","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.beha.2011.02.008_bib8","unstructured":"NCCN guidelines\u2122 and derivative information products: user guide http:\/\/www.nccn.org\/clinical.asp. Available from: www.nccn.org."},{"key":"10.1016\/j.beha.2011.02.008_bib9","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdn096","article-title":"Newly diagnosed and relapsed follicular lymphoma: ESMO clinical recommendations for diagnosis, treatment and follow-up","volume":"19","author":"Dreyling","year":"2008","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.beha.2011.02.008_bib10","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1200\/JCO.1996.14.4.1282","article-title":"Is radiotherapy curative for stage I and II low-grade follicular lymphoma? Results of a long-term follow-up study of patients treated at Stanford University","volume":"14","author":"Mac Manus","year":"1996","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.beha.2011.02.008_bib11","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.ijrobp.2005.08.010","article-title":"Long-term outcome and mortality trends in early-stage, grade 1\u20132 follicular lymphoma treated with radiation therapy","volume":"64","author":"Guadagnolo","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"5","key":"10.1016\/j.beha.2011.02.008_bib12","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1007\/s00066-009-1937-4","article-title":"Long-term outcome and prognostic factors in early-stage nodal low-grade non-hodgkin\u2019s lymphomas treated with radiation therapy","volume":"185","author":"Eich","year":"2009","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"10.1016\/j.beha.2011.02.008_bib13","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/S0360-3016(01)01747-3","article-title":"Long-term results with radiotherapy for stage I-II follicular lymphomas","volume":"51","author":"Wilder","year":"2001","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"4","key":"10.1016\/j.beha.2011.02.008_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00066-010-2090-9","article-title":"Nodal follicular lymphoma: the role of radiotherapy for stages I and II","volume":"186","author":"Heinzelmann","year":"2010","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"10.1016\/j.beha.2011.02.008_bib15","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-Celigny","year":"2004","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.beha.2011.02.008_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/j.1600-0609.2005.00564.x","article-title":"Follicular lymphoma in early stages: high risk of relapse and usefulness of the follicular lymphoma international prognostic index to predict the outcome of patients","volume":"76","author":"Plancarte","year":"2006","journal-title":"Eur J Haematol"},{"issue":"14S","key":"10.1016\/j.beha.2011.02.008_bib17","first-page":"652","article-title":"Long-term outcome in stage I and II follicular lymphoma following treatment with involved field radiation therapy alone","volume":"22","author":"Petersen","year":"2004","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.beha.2011.02.008_bib18","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0167-8140(95)01600-L","article-title":"Radiotherapy results in early stage low grade nodal non-Hodgkin\u2019s lymphoma","volume":"36","author":"Pendlebury","year":"1995","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.beha.2011.02.008_bib19","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0025-7125(16)33107-8","article-title":"The treatment of Hodgkin\u2019s disease","volume":"50","author":"Kaplan","year":"1966","journal-title":"Med Clin North Am"},{"issue":"3","key":"10.1016\/j.beha.2011.02.008_bib20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.radonc.2006.05.015","article-title":"Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines","volume":"79","author":"Girinsky","year":"2006","journal-title":"Radiother Oncol"},{"issue":"1","key":"10.1016\/j.beha.2011.02.008_bib21","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/0360-3016(93)90173-S","article-title":"Radiotherapy is successful treatment for orbital lymphoma","volume":"26","author":"Smitt","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.beha.2011.02.008_bib22","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1148\/108.3.675","article-title":"Recurrence rates following radiation therapy of nodular and diffuse malignant lymphomas","author":"Fuks","year":"1973","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.beha.2011.02.008_bib23","first-page":"1129","article-title":"Radiation therapy of localized non-Hodgkin\u2019s lymphoma","volume":"61","author":"Bush","year":"1977","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/j.beha.2011.02.008_bib24","article-title":"Radiation dose in non-Hodgkin\u2019s lymphoma: preliminary results of UK NCRN randomised trial","author":"Hoskin","year":"2005","journal-title":"European Society of Medical Oncology"},{"issue":"1","key":"10.1016\/j.beha.2011.02.008_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/hon.2900120102","article-title":"Potential role for low dose limited-field radiation therapy (2\u00a0\u00d7\u00a02 grays) in advanced low-grade non-Hodgkin\u2019s lymphomas","volume":"12","author":"Ganem","year":"1994","journal-title":"Hematol Oncol"},{"issue":"13","key":"10.1016\/j.beha.2011.02.008_bib26","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1200\/JCO.2003.09.542","article-title":"High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas","volume":"21","author":"Haas","year":"2003","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.beha.2011.02.008_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0360-3016(98)00233-8","article-title":"What is the prognosis for patients who relapse after primary radiation therapy for early-stage low-grade follicular lymphoma?","volume":"42","author":"Mac Manus","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"3","key":"10.1016\/j.beha.2011.02.008_bib28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1046\/j.1440-1673.2001.00930.x","article-title":"Management of localized low-grade follicular lymphomas","volume":"45","author":"MacManus","year":"2001","journal-title":"Australas Radiol"},{"issue":"11","key":"10.1016\/j.beha.2011.02.008_bib29","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1200\/JCO.2003.07.111","article-title":"Long-term follow-up of a prospective study of combined modality therapy for stage I\u2013II indolent non-Hodgkin\u2019s lymphoma","volume":"21","author":"Seymour","year":"2003","journal-title":"J Clin Oncol"},{"issue":"3","key":"10.1016\/j.beha.2011.02.008_bib30","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1002\/ijc.1018","article-title":"Ionizing radiation induces CD20 surface expression on human B cells","volume":"96","author":"Kunala","year":"2001","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.beha.2011.02.008_bib31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0360-3016(97)00722-0","article-title":"Place of low-dose total body irradiation in the treatment of localized follicular non-Hodgkin\u2019s lymphoma: results of a pilot study","volume":"40","author":"Richaud","year":"1998","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.beha.2011.02.008_bib32","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/oxfordjournals.annonc.a010720","article-title":"Is there any place for a wait-and-see policy in stage I0 follicular lymphoma? A study of 43 consecutive patients in a single center","volume":"7","author":"Soubeyran","year":"1996","journal-title":"Ann Oncol"},{"issue":"8","key":"10.1016\/j.beha.2011.02.008_bib33","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1200\/JCO.2004.10.086","article-title":"Stage I and II follicular non-Hodgkin\u2019s lymphoma: long-term follow-up of no initial therapy","volume":"22","author":"Advani","year":"2004","journal-title":"J Clin Oncol"},{"issue":"14S","key":"10.1016\/j.beha.2011.02.008_bib34","first-page":"652","article-title":"Long-term outcome in stage I and II follicular lymphoma following treatment with involved field radiation therapy alone","volume":"22","author":"Petersen","year":"2004","journal-title":"J Clin Oncol"}],"container-title":["Best Practice & Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692611000260?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692611000260?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T03:54:00Z","timestamp":1560138840000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692611000260"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,6]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["S1521692611000260"],"URL":"https:\/\/doi.org\/10.1016\/j.beha.2011.02.008","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2011,6]]}}}